Master regulators of FGFR2 signalling and breast cancer risk

190Citations
Citations of this article
264Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The fibroblast growth factor receptor 2 (FGFR2) locus has been consistently identified as a breast cancer risk locus in independent genome-wide association studies. However, the molecular mechanisms underlying FGFR2-mediated risk are still unknown. Using model systems we show that FGFR2-regulated genes are preferentially linked to breast cancer risk loci in expression quantitative trait loci analysis, supporting the concept that risk genes cluster in pathways. Using a network derived from 2,000 transcriptional profiles we identify SPDEF, ERα, FOXA1, GATA3 and PTTG1 as master regulators of fibroblast growth factor receptor 2 signalling, and show that ERα occupancy responds to fibroblast growth factor receptor 2 signalling. Our results indicate that ERα, FOXA1 and GATA3 contribute to the regulation of breast cancer susceptibility genes, which is consistent with the effects of anti-oestrogen treatment in breast cancer prevention, and suggest that fibroblast growth factor receptor 2 signalling has an important role in mediating breast cancer risk. © 2013 Macmillan Publishers Limited. All rights reserved.

Cite

CITATION STYLE

APA

Fletcher, M. N. C., Castro, M. A. A., Wang, X., De Santiago, I., O’Reilly, M., Chin, S. F., … Meyer, K. B. (2013). Master regulators of FGFR2 signalling and breast cancer risk. Nature Communications, 4. https://doi.org/10.1038/ncomms3464

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free